VCM
GMED icon

Versant Capital Management’s Globus Medical GMED Stock Holding History

Versant Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
3,842
+1,547
+67% +$131K 0.03% 461
2026
Q1 		$198K Buy
2,295
+1,972
+611% +$177K 0.02% 592
2025
Q4 		$28.2K Buy
323
+281
+669% +$21.3K ﹤0.01% 1428
2025
Q3 		$2.4K Buy
42
+6
+17% +$346 ﹤0.01% 2380
2025
Q2 		$2.13K Sell
36
-511
-93% -$33K ﹤0.01% 2366
2025
Q1 		$40K Buy
547
+494
+932% +$40.8K 0.01% 965
2024
Q4 		$4.38K Buy
+53
New +$4.18K ﹤0.01% 1820
2024
Q2 		– Sell
-4
Closed -$215 – 1973
2024
Q1 		$215 Hold
4
– – ﹤0.01% 1823
2023
Q4 		$213 Sell
4
-203
-98% -$9.89K ﹤0.01% 1861
2023
Q3 		$10.3K Buy
207
+77
+59% +$4.31K ﹤0.01% 722
2023
Q2 		$7.74K Sell
130
-3
-2% -$171 ﹤0.01% 870
2023
Q1 		$7.53K Buy
+133
New +$8.53K ﹤0.01% 809
2020
Q1 		– Sell
-3
Closed – – 1442
2019
Q4 		$0 Buy
+3
New +$163 ﹤0.01% 1435

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Versant Capital Management's GMED Position: Q2 2026 in Review

Versant Capital Management increased its Globus Medical (GMED) stake by 67% in Q2 2026, buying an estimated $131K and bringing the position to 3,842 shares worth $304K. The position accounts for 0.03% of the portfolio, ranked #461.

Versant Capital Management first reported a position in GMED in Q4 2019 and has held it in 13 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Versant Capital Management held 3,842 shares of Globus Medical worth $304K as of Q2 2026.
  • Versant Capital Management bought 1,547 Globus Medical shares in Q2 2026, an estimated $131K.
  • Globus Medical made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #461 holding.
  • Versant Capital Management first reported a position in Globus Medical in Q4 2019 and has held it in 13 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.